Skip to main content

Zimmer Biomet Holdings Value Stock - Dividend - Research Selection

Zimmer

ISIN: US98956P1021 , WKN: 753718

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company\'s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Zimmer Biomet Holdings, Inc. (ZBH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13
Zimmer Biomet Holdings, Inc. (ZBH) 44th Annual J.P.

Zimmer Biomet’s Q3 2025 Earnings: What to Expect

2026-01-13
Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

Stage Set For Moat Stocks After Strong 2025 Close

2026-01-13

Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

2026-01-12
CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona’s continued focus on strengthening commercial execution, deepening customer relationships and accel

Zimmer Biomet (ZBH) Valuation Check After Fresh Evercore Upgrade To Outperform

2026-01-09
Zimmer Biomet Holdings (ZBH) is back in focus after Evercore ISI Group upgraded the stock from In Line to Outperform, a shift that follows earlier downgrades and signals changing analyst sentiment. See our latest analysis for Zimmer Biomet Holdings. Recent analyst calls, including the latest upgrade, come as Zimmer Biomet’s share price sits at $94.08, with short term momentum improving but longer term total shareholder returns over 1, 3 and 5 years remaining negative. If this kind of...

Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance

2026-01-09
Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid moat. Click for why I'm bullish on ISRG.

3 S&P 500 Stocks We Approach with Caution

2026-01-09
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Smith & Nephew: Improving And Undervalued, But Mind The Knees

2026-01-07
Smith & Nephew (SNN) outlook: sports medicine and wound care strength vs ortho weakness. Read here for an investment analysis of SNN stock.

Despite Reassurances On Growth, The Market Hasn't Warmed To Stryker

2026-01-07
Stryker outlook: 9%+ FY’26 growth, margin leverage, and attractive valuation vs. med-tech peers. See why I rate SYK stock a Buy.

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, CoreWeave, Digital Realty, Palantir Technologies, ServiceNow, Shopify, SoFi Technologies, and More

2026-01-06
Pre-Market Stock Futures: The futures are little changed after a blockbuster day to open the first full trading week of 2026. The combination of no Santa Claus rally, the market shrugging off the capture of Venezuelan dictator Maduro, then embracing the action, plus some big pent-up money sitting on the sidelines, all helped to propel ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, CoreWeave, Digital Realty, Palantir Technologies, ServiceNow, Shopify, SoFi Technologies, and